636
Views
4
CrossRef citations to date
0
Altmetric
Author's View

BRAF-targeted therapy alters the functions of intratumoral CD4+ T cells to inhibit melanoma progression

&
Article: e29126 | Received 30 Apr 2014, Accepted 06 May 2014, Published online: 18 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Blanca Homet Moreno, Stephen Mok, Begonya Comin-Anduix, Siwen Hu-Lieskovan & Antoni Ribas. (2016) Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma. OncoImmunology 5:7.
Read now

Articles from other publishers (3)

Wolfram Samlowski & Camille Adajar. (2021) Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy. BMC Cancer 21:1.
Crossref
Manali S. Phadke, Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley, Derek R. Duckett, Vinayak Palve, Brian J. Czerniecki, Peter A. Forsyth, David Noyes, Dennis O. Adeegbe, Zeynep Eroglu, Kimberly T. Nguyen, Kenneth Y. Tsai, Uwe Rix, Christin E. Burd, Yian A. Chen, Paulo C. Rodriguez & Keiran S.M. Smalley. (2021) Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity. Cancer Immunology Research 9:5, pages 554-567.
Crossref
Ingrid Böhm, Stephan Gehrke, Beate Kleb, Martin Hungerbühler, Rolf Müller, Klaus J Klose & Heiko Alfke. (2018) Monitoring of tumor burden in vivo by optical imaging in a xenograft SCID mouse model: evaluation of two fluorescent proteins of the GFP-superfamily. Acta Radiologica 60:3, pages 315-326.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.